A Clinical Trial Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Conditions: Beta-Thalassemia Interventions: Genetic: CS-101 Sponsors: CorrectSequence Therapeutics Co., Ltd; First Affiliated Hospital of Guangxi Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials